Curated News
By: NewsRamp Editorial Staff
March 10, 2026
HeartBeam and Mount Sinai Partner to Advance AI-Driven Cardiac Monitoring
TLDR
- HeartBeam's collaboration with Mount Sinai accelerates AI-ECG development, offering a competitive edge in remote cardiac monitoring and preventive cardiology markets.
- HeartBeam combines its 3D ECG platform with Mount Sinai's clinical datasets to train AI models for personalized cardiac insights using synthesized 12-lead ECG data.
- This partnership advances remote patient monitoring, making cardiac care more accessible and potentially improving outcomes in chronic disease management worldwide.
- HeartBeam's FDA-cleared technology captures 3D heart signals to create 12-lead ECGs, enabling portable cardiac monitoring outside medical facilities.
Impact - Why it Matters
This collaboration matters because it addresses critical gaps in cardiac care by combining cutting-edge technology with clinical expertise to enhance remote monitoring and personalized treatment. Heart disease remains a leading cause of death globally, and traditional ECG methods often require in-person visits, limiting accessibility and timely intervention. By developing AI-ECG algorithms that can be used in home settings, this partnership has the potential to revolutionize preventive cardiology and chronic disease management, making it easier for patients to receive continuous, accurate monitoring without frequent hospital trips. This could lead to earlier detection of cardiac issues, reduced healthcare costs, and improved outcomes for millions of people, especially those in remote or underserved areas. The integration of AI with ECG data also paves the way for more proactive and data-driven healthcare, aligning with broader trends toward digital health and telemedicine.
Summary
HeartBeam (NASDAQ: BEAT), a pioneering medical technology company, has announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the development of next-generation AI-ECG algorithms. This partnership combines HeartBeam's patented 3D ECG platform, which captures the heart's electrical activity from three non-coplanar dimensions and synthesizes it into a 12-lead ECG, with Mount Sinai's clinically annotated 12-lead ECG datasets and artificial intelligence expertise. The collaboration leverages longitudinal, high-fidelity synthesized 12-lead ECG data collected from patients in home settings alongside Mount Sinai's clinical resources to train and validate AI models that support personalized cardiac insights, expand clinical indications, and enable broader applications in preventive cardiology, chronic disease management, and remote patient monitoring.
HeartBeam's technology represents a significant advancement in cardiac care, as it creates the first-ever cable-free device capable of collecting ECG signals in 3D and synthesizing them into a 12-lead ECG. This platform is designed for portable devices that can be used wherever the patient is, delivering actionable heart intelligence to physicians who can identify cardiac health trends and acute conditions outside of medical facilities. The company's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, with the 12-lead ECG synthesis software cleared in December 2025, and it holds over 20 issued patents. The collaboration aims to redefine the future of cardiac health management by enhancing AI-driven monitoring and expanding the potential of remote diagnostics.
This news was distributed via BioMedWire, a specialized communications platform within the Dynamic Brand Portfolio at IBN, which provides access to wire solutions, article syndication, press release enhancement, social media distribution, and tailored corporate communications solutions. For more details, readers can view the full press release at the provided link. The partnership underscores a growing trend in healthcare toward integrating advanced technology with clinical expertise to improve patient outcomes and accessibility, positioning HeartBeam and Mount Sinai at the forefront of innovation in cardiac care.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, HeartBeam and Mount Sinai Partner to Advance AI-Driven Cardiac Monitoring
